Skip to main content
OpenTrials
Completed

NCT Number: NCT02032069

Pneumoproteins Expression in the Organ Donor

Primary graft dysfunction, a form of reperfusion pulmonary edema that occurs early after lung transplantation, shares key clinical and pathological features with acute lung injury and its more severe form, the acute respiratory distress syndrome. However, in contrast to acute lung injury/acute respiratory distress syndrome, in which biomarkers in plasma, urine and lung edema fluid have prognostic and pathogenetic value, the role of biomarkers in primary graft dysfunction has been less thoroughly explored. We will try in this study de determine the rule of pneumoproteins in the donor organ on the pulmonary edema in the recipient.

Completed

Looking for future studies?

Notify Me

Key information

Age range

5 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Mont-Godinne

Yvoir, Namur, 5530, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All the organ donors for lung grafts.

Exclusion criteria

none

Treatment and study plan

No intervention

Other

Primary outcomes

  1. Number of Recipient with primary graft dysfunction

    Time frame: one year

Sponsors and collaborators

Lead sponsor

University Hospital of Mont-Godinne

Other

Registry information

Important dates

Study start
2013
Primary completion
2016
Study completion
2016
First posted
Jan 9, 2014
Registry last updated
Mar 15, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.